CYDX (Cyduct Diagnostics) Probability of Financial Distress (%)


What is Cyduct Diagnostics Probability of Financial Distress (%)?

Cyduct Diagnostics does not have enough data to calculate Probability of Financial Distress (%).


Cyduct Diagnostics  (OTCPK:CYDX) Probability of Financial Distress (%) Explanation

Like the Altman Z-Score, the PFD measures a company's bankruptcy risk in the upcoming year. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.


Cyduct Diagnostics Probability of Financial Distress (%) Related Terms


Cyduct Diagnostics Probability of Financial Distress (%) Historical Data

* Premium members only.

The historical data trend for Cyduct Diagnostics's Probability of Financial Distress (%) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyduct Diagnostics Probability of Financial Distress (%) Chart

Cyduct Diagnostics Annual Data
Trend
Probability of Financial Distress (%)

Cyduct Diagnostics Quarterly Data
Probability of Financial Distress (%)

CYDX vs SECI, QTXB, ASNB: Probability of Financial Distress (%) Comparison

For the Medical Devices subindustry, Cyduct Diagnostics's Probability of Financial Distress (%), along with its competitors' market caps and Probability of Financial Distress (%) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyduct Diagnostics Probability of Financial Distress (%) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cyduct Diagnostics's Probability of Financial Distress (%) distribution charts can be found below:

* The bar in red indicates where Cyduct Diagnostics's Probability of Financial Distress (%) falls into.



Cyduct Diagnostics Business Description

Address 1698 Post Road East, Suite 1A, Westport, CT, USA, 06880
Cyduct Diagnostics Inc is a clinical-stage diagnostic company. It focuses on creating and enhancing a portfolio of technologies and assets based on the early assessment and detection of Breast Cancer. Its technology platform of MammoView devices is a single-use, high-margin product that assesses, screens, detects, monitors, and facilitates the treatment of identifiable changes that distinguish variations in breast health. The company markets these products under its Solos Endoscopy brand, along with a line of branded surgical instruments, manufactured by third parties to its design specifications, mainly endoscopes and hand-held surgical instruments for the minimally invasive surgery market.